The effect of menstrual status on the surgical cure of breast cancer has been studied since Hrushesky and colleagues first reported their finding that women operated on during their perimenstrual period had a higher risk of developing metastasis than women operated on at mid-cycle Ratajczak et al., 1988) . Since then several conflicting results have been published. There is, however, a lack of biological credibility in the observed differences on survival owing to the timing of the operation in premenopausal women (Badwe et al., 1991; Hrushesky, 1991; Senie et al., 1991) . The aim of this study was to evaluate the effect of the timing of surgery in relation to menstrual cycle on survival and to assess the confounding effect of other known prognostic factors.
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Materials and methods

Patient population
The patient population is based on the database of the Steroid Receptor Laboratory (University of Tampere, Department of Clinical Sciences, Tampere, Finland) , which annually performed 200-300 steroid receptor assays for local hospitals every year during the study period 1980-87.
Premenopausal breast cancer patients, the date of whose last menstrual period was recorded by surgeons (available from 60% of patients), entered this study (n = 267). Patients receiving steroid hormone therapy or whose last menstrual period had occurred more than 32 days before surgery were excluded (n = 34). The date of the last menstrual period, the date of surgery, the size of the primary tumour and steroid receptor concentrations were provided by the steroid receptor database. Follow-up data and TNM classification were taken from the Finnish Cancer Registry (Hakulinen et al., 1981 ).
The patients were followed for death up to the date (1 July 1992) on which the study closed.
The potential effect of the timing of the operation in 
Results
The 5 year survival of all 445 patients was 70%. The survival of the 267 patients included in this study did not differ from that of the 178 premenopausal patients for whom data on LMP were not available and who were operated on in the same time period. When the hormone-dependent phase was used as cut-off, the 5 year survival increased linearly for the patients with surgery during the early follicular phase survival to the late luteal phase (Figure 1 ). Patients operated on days 15-32 had better 5 year survival than patients operated Badwe et al.. 1991; Hrushesky. 1991 : Senie et al., 1991 , indicating that the timing of surgery in relation to the phase of the menstrual cycle may have an impact on survival. A statistically significant decrease of 1% in mortality by 1 day since last menstrual period was observed.
There is a theoretical consideration that hormonal receptor protein levels can be related to endogenous hormone levels, depending on the phase of the menstrual cycle. Some investigators have tried to establish if tumour sex steroid receptors vary with the phase of the menstrual cycle. Again, results differ greatly. Some investigators found higher levels during the proliferative phase (days 1-14) than dunrng the secretory phase (days 15-32) (Heise and G6rlich, 1982; Axelrod et al.. 1988 : Smyth et al., 1988 . whereas Weimer and Donegan (1987) measured the highest values in the late luteal phase. Coradini et al. (1984) reported a higher concentration of progesterone receptor protein in the early luteal phase (days [16] [17] [18] [19] [20] [21] [22] . The overall conclusion of previous studies is that there is no consistent variation in oestrogen receptor protein levels during the menstrual cycle. We found a higher prevalence in the positivity of oestrogen receptor protein in the early follicular phase, and the level of concentration was also somewhat higher. The progesterone receptor protein concentration was highest in the late follicular and late luteal phases, but none of these variations was significant. We were able to evaluate independently the prognostic value of timing of surgery by adjusting the effect of hormonal receptor levels by multivariate analyses. LMP timing in relation to surgery remained an independent prognostic factor after such an adjustment.
Other explanations besides those citing hormones have been also put forward. In their reports McGuire (1991) and McGuire et al. (1992) have critically discussed the optimal timing of surgery. They suggest that at least some of the reported results may be fallacious and due to chance alone. However, they conclude that not all the differences may be accounted for by random vanation alone in every study.
Our results are consistent with those showing an effect of timing of the operation on the survival of breast cancer patients. Our multivariate analysis implied that the timing of the operation could not be accounted for by the other prognostic factors. The effect of day since last menstrual period may be due to correlation of the immune status of the woman with the menstrual cycle. The variation in survival may also simply be due to physiological variation in the size and consistency of breast and lymph nodes at different phases of the menstrual cycle affecting the ease and quality of the diagnosis and the operation.
